0.6266
price down icon5.03%   -0.0332
after-market 시간 외 거래: .61 -0.0166 -2.65%
loading
전일 마감가:
$0.6598
열려 있는:
$0.6582
하루 거래량:
3.02M
Relative Volume:
0.21
시가총액:
$227.57M
수익:
$1.21M
순이익/손실:
$-177.12M
주가수익비율:
-0.7833
EPS:
-0.8
순현금흐름:
$-162.37M
1주 성능:
-5.05%
1개월 성능:
-6.31%
6개월 성능:
-22.04%
1년 성능:
-63.14%
1일 변동 폭
Value
$0.6217
$0.681
1주일 범위
Value
$0.6217
$0.7153
52주 변동 폭
Value
$0.2836
$2.45

렉시콘 파마슈티컬스 Stock (LXRX) Company Profile

Name
명칭
Lexicon Pharmaceuticals Inc
Name
전화
(281) 863-3000
Name
주소
2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS
Name
직원
103
Name
트위터
@LexPharma
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
LXRX's Discussions on Twitter

LXRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LXRX
Lexicon Pharmaceuticals Inc
0.6266 239.66M 1.21M -177.12M -162.37M -0.80
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

렉시콘 파마슈티컬스 Stock (LXRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-05 다운그레이드 Leerink Partners Outperform → Market Perform
2024-06-17 개시 H.C. Wainwright Buy
2024-04-30 개시 Leerink Partners Outperform
2023-03-07 개시 Jefferies Hold
2022-08-12 개시 Piper Sandler Overweight
2021-01-29 업그레이드 JP Morgan Underweight → Neutral
2021-01-29 다운그레이드 Wedbush Outperform → Neutral
2020-12-08 업그레이드 Citigroup Neutral → Buy
2020-11-18 업그레이드 Gabelli & Co Hold → Buy
2019-12-11 다운그레이드 Gabelli & Co Buy → Hold
2019-11-08 다운그레이드 Citigroup Buy → Neutral
2019-09-11 업그레이드 Gabelli & Co Hold → Buy
2019-07-29 다운그레이드 Stifel Buy → Hold
2019-03-25 업그레이드 Gabelli & Co Sell → Hold
2018-07-31 재확인 Stifel Buy
2018-02-23 다운그레이드 Needham Buy → Hold
2018-02-14 다운그레이드 JP Morgan Neutral → Underweight
2017-03-01 재확인 H.C. Wainwright Buy
2017-03-01 재확인 Wedbush Outperform
2016-10-07 개시 H.C. Wainwright Buy
2016-08-05 재확인 Wedbush Outperform
2016-08-02 개시 Citigroup Buy
2016-03-02 재확인 Wedbush Outperform
2015-11-09 재확인 Wedbush Outperform
2015-09-28 업그레이드 Gabelli & Co Sell → Hold
2015-09-18 다운그레이드 Gabelli & Co Hold → Sell
2015-08-10 다운그레이드 JP Morgan Overweight → Neutral
모두보기

렉시콘 파마슈티컬스 주식(LXRX)의 최신 뉴스

pulisher
May 30, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Shares Bought by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 29, 2025

Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 29, 2025
pulisher
May 21, 2025

Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential - MSN

May 21, 2025
pulisher
May 20, 2025

13 Best Multibagger Stocks to Invest in Now - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

Lexicon (LXRX) Advances Study on Sotagliflozin for Heart Conditions | LXRX Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

LXRXLexicon Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Analysts Just Made A Noticeable Upgrade To Their Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Forecasts - simplywall.st

May 19, 2025
pulisher
May 17, 2025

Earnings Update: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance

May 17, 2025
pulisher
May 15, 2025

Lexicon targets late 2025 Phase 3 start for pilavapadin and expands LX9851 partnership with Novo Nordisk - MSN

May 15, 2025
pulisher
May 15, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals (LXRX) Reports Higher Q1 Revenue and Key Strategic Developments | LXRX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals (LXRX) Pre-Earnings Options Activity Rev - GuruFocus

May 14, 2025
pulisher
May 14, 2025

LEXICON PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Shares Bought by Barclays PLC - Defense World

May 14, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlig - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Lexicon: Q1 Earnings Snapshot - New Haven Register

May 14, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals (LXRX) Secures Major Licensing Deal with Novo Nordisk - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LXRX) - Seeking Alpha

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Lexicon Q1 2025 beats EPS expectations, stock declines - Investing.com

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings: EPS Beats E - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Lexicon Pharmaceuticals Q1 Operating Income USD -25.679 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Lexicon Secures Massive $1B Novo Nordisk Partnership While Advancing Breakthrough Pain Drug Trial - Stock Titan

May 13, 2025
pulisher
May 12, 2025

A Preview Of Lexicon Pharmaceuticals's Earnings - Nasdaq

May 12, 2025
pulisher
May 07, 2025

Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference - The Manila Times

May 07, 2025
pulisher
May 06, 2025

Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference | LXRX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Lexicon Pharmaceuticals Announces Exclusive Fireside Chat at HC Wainwright BioConnect Conference - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Lexicon Pharmaceuticals Sets Q1 2025 Earnings Date: Key Financial Updates Coming May 13 - Stock Titan

May 06, 2025
pulisher
Apr 30, 2025

Carcinoid Syndrome Diarrhea Treatment Market To Reach US$ - openPR.com

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 27, 2025

Lexicon Pharmaceuticals, Inc. (LXRX)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action & Lead Plaintiff Deadline: April 1, 2019 - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Top 2 Health Care Stocks That May Crash This Month - Benzinga

Apr 25, 2025
pulisher
Apr 22, 2025

Form ARS LEXICON PHARMACEUTICALS, For: Dec 31 - StreetInsider

Apr 22, 2025
pulisher
Apr 09, 2025

Lexicon Pharmaceuticals at Needham Conference: Strategic Shift in Focus By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Novo Nordisk inks licensing pact with Lexicon for obesity candidate - MSN

Apr 09, 2025
pulisher
Apr 02, 2025

LXRX Stock Moves Up 30% in a Week: What is Driving This Rally? - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Lexicon Pharmaceuticals to present at Healthcare Conference By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Lexicon Pharmaceuticals to present at Healthcare Conference - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Apr 02, 2025

렉시콘 파마슈티컬스 (LXRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):